nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/lpr lupus mice
|
Huang, M W |
|
2019 |
28 |
13 |
p. 1510-1523 |
artikel |
2 |
Associations between paraoxonase-1 and systemic lupus erythematosus
|
Bae, S -C |
|
2019 |
28 |
13 |
p. 1571-1576 |
artikel |
3 |
Characteristics of lupus and lupus nephritis at a tertiary care center in Lebanon
|
Koubar, S H |
|
2019 |
28 |
13 |
p. 1598-1603 |
artikel |
4 |
Clinical characteristics and risk factors of microvascular involvement in primary antiphospholipid syndrome: a longitudinal single-center study in China
|
Sun, Y |
|
2019 |
28 |
13 |
p. 1558-1565 |
artikel |
5 |
Complementemia in pregnancies with antiphospholipid syndrome
|
Tabacco, S |
|
2019 |
28 |
13 |
p. 1503-1509 |
artikel |
6 |
Complete heart block in lupus
|
Natsheh, A |
|
2019 |
28 |
13 |
p. 1589-1593 |
artikel |
7 |
Corrigendum to Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/lpr lupus mice
|
|
|
2019 |
28 |
13 |
p. 1615 |
artikel |
8 |
Dermoscopy in the differential diagnosis between malar rash of systemic lupus erythematosus and erythematotelangiectatic rosacea: an observational study
|
Errichetti, E |
|
2019 |
28 |
13 |
p. 1583-1588 |
artikel |
9 |
Effect of air pollution on hospital admissions for systemic lupus erythematosus in Bengbu, China: a time series study
|
Zhao, C -N |
|
2019 |
28 |
13 |
p. 1541-1548 |
artikel |
10 |
Factor Xa inhibitors for preventing recurrent thrombosis in patients with antiphospholipid syndrome: a longitudinal cohort study
|
Sato, T |
|
2019 |
28 |
13 |
p. 1577-1582 |
artikel |
11 |
Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus
|
Pinto, B |
|
2019 |
28 |
13 |
p. 1534-1540 |
artikel |
12 |
Incidence of systemic lupus erythematosus in Colombia: data from the National Health Registry 2012–2016
|
Haase, I |
|
2019 |
28 |
13 |
p. 1610-1611 |
artikel |
13 |
Myelofibrosis associated with systemic lupus erythematosus successfully treated with rituximab
|
Kaul, A |
|
2019 |
28 |
13 |
p. 1612-1614 |
artikel |
14 |
Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features
|
Whittall-García, L P |
|
2019 |
28 |
13 |
p. 1549-1557 |
artikel |
15 |
Secondary acute angle closure attack as an initial presentation of a novel type of systemic lupus erythematosus
|
Sun, H -S |
|
2019 |
28 |
13 |
p. 1594-1597 |
artikel |
16 |
The clinical characteristics of systemic lupus erythematosus patients in Indonesia: a cohort registry from an Indonesia-based tertiary referral hospital
|
Hamijoyo, L |
|
2019 |
28 |
13 |
p. 1604-1609 |
artikel |
17 |
Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients
|
Nieto-Aristizábal, I |
|
2019 |
28 |
13 |
p. 1566-1570 |
artikel |
18 |
Type I interferon gene signature test–low and –high patients with systemic lupus erythematosus have distinct gene expression signatures
|
Brohawn, PZ |
|
2019 |
28 |
13 |
p. 1524-1533 |
artikel |